Literature DB >> 11687304

Probing the molecular basis of factor Xa specificity by mutagenesis of the serpin, antithrombin.

A R Rezaie1, L Yang.   

Abstract

The molecular basis of the substrate and inhibitor specificity of factor Xa, the serine proteinase of the prothrombinase complex, was investigated by constructing two mutants of human antithrombin (HAT) in which the reactive site loop of the serpin from the P4-P4' site was replaced with the corresponding residues of the two factor Xa cleavage sites in prothrombin (HAT/Proth-1 and HAT/Proth-2). These mutants together with prethrombin-2, the smallest zymogen form of thrombin containing only the second factor Xa cleavage site, were expressed in mammalian cells, purified to homogeneity and characterized in kinetic reactions with factor Xa in both the absence and presence of cofactors; factor Va, high affinity heparin and pentasaccharide fragment of heparin. HAT/Proth-1 inactivated factor Xa approximately 3-4-fold better than HAT/Proth-2 in either the absence or presence of heparin cofactors. In the absence of a cofactor, factor Xa reacted with the HAT/Proth-2 and prethrombin-2 with similar second-order rate constants (approximately 2-3x10(2) M(-1)s(-1)). Pentasaccharide catalyzed the inactivation rate of factor Xa by the HAT mutants 300-500-fold. A similar 10(4)-10(5)-fold enhancement in the reactivity of factor Xa with prethrombin-2 and the HAT mutants was observed in the presence of the cofactors Va and heparin, respectively. Factor Va did not influence the reactivity of factor Xa with either one of the HAT mutants. These results suggest that (1) in the absence of a cofactor, the P4-P4' residues of HAT and prethrombin-2 primarily determine the specificity reactions with factor Xa, (2) factor Va binding to factor Xa is not associated with allosteric changes in the catalytic pocket of enzyme that would involve interactions with the P4-P4' binding sites, and (3) similar to allosteric activation of HAT by heparin, a role for factor Va in the prothrombinase complex may involve rearrangement of the residues surrounding the scissile bond of the substrate to facilitate its optimal docking into the catalytic pocket of factor Xa.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687304     DOI: 10.1016/s0304-4165(01)00189-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.

Authors:  Lin Chen; Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

2.  The functional significance of the autolysis loop in protein C and activated protein C.

Authors:  Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2005-07       Impact factor: 5.249

3.  Inhibitory properties of the P1 Tyr variant of antithrombin.

Authors:  Likui Yang; Chandrashekhara Manithody; Shabir H Qureshi; Alireza R Rezaie
Journal:  Biochemistry       Date:  2010-03-30       Impact factor: 3.162

4.  Plasmodium falciparum histidine rich protein HRPII inhibits the anti-inflammatory function of antithrombin.

Authors:  Peyman Dinarvand; Likui Yang; Indranil Biswas; Hemant Giri; Alireza R Rezaie
Journal:  J Thromb Haemost       Date:  2020-01-14       Impact factor: 5.824

5.  Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.

Authors:  Likui Yang; Chandrashekhara Manithody; Shabir H Qureshi; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

6.  Thr90Ser Mutation in Antithrombin is Associated with Recurrent Thrombosis in a Heterozygous Carrier.

Authors:  Yeling Lu; Bruno O Villoutreix; Indranil Biswas; Qiulan Ding; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2020-05-18       Impact factor: 5.249

7.  Expression and functional characterization of two natural heparin-binding site variants of antithrombin.

Authors:  P Dinarvand; L Yang; B O Villoutreix; A R Rezaie
Journal:  J Thromb Haemost       Date:  2018-01-08       Impact factor: 5.824

8.  Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.

Authors:  Alireza R Rezaie; Chandrashekhara Manithody; Likui Yang
Journal:  J Biol Chem       Date:  2005-08-03       Impact factor: 5.157

9.  Antithrombin is protective against myocardial ischemia and reperfusion injury.

Authors:  J Wang; Y Wang; J Wang; J Gao; C Tong; C Manithody; J Li; A R Rezaie
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

10.  Role of P2 glycine in determining the specificity of antithrombin reaction with coagulation proteases.

Authors:  Likui Yang; Shabir H Qureshi; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Biochem Biophys Res Commun       Date:  2009-08-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.